Skip to main content

A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Dose Escalating Study of SGX942 for Oral Mucositis in Patients With Head and Neck Cancer

MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer

Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Collaborative Care to Reduce Depression and Increase Cancer Screening Among Low-Income Urban Women

Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer

Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study of Azacitidine With or Without Birinapant in Subjects With MDS or CMMoL

A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Phase 2, Multicenter, Randomized, Open-label Study of MEDI-551 in Adults With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1)

A Phase 1/2 Study to Evaluate MEDI4736

Submitted by Anonymous (not verified) on Tue, 07/19/2022 - 15:18
  • Read more about A Phase 1/2 Study to Evaluate MEDI4736

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 164
  • Page 165
  • Page 166
  • Page 167
  • Page 168
  • Page 169
  • Page 170
  • Page 171
  • Page 172
  • …
  • Next page Next
  • Last page Last
Subscribe to